138 related articles for article (PubMed ID: 16901851)
1. In vivo veritas: thrombosis mechanisms in animal models.
Napoli C; De Nigris F; Pignalosa O; Lerman A; Sica G; Fiorito C; Sica V; Chade A; Lerman LO
Scand J Clin Lab Invest; 2006; 66(5):407-27. PubMed ID: 16901851
[TBL] [Abstract][Full Text] [Related]
2. Overview of murine thrombosis models.
Whinna HC
Thromb Res; 2008; 122 Suppl 1():S64-9. PubMed ID: 18691503
[TBL] [Abstract][Full Text] [Related]
3. Atherosclerosis and thrombosis: lessons from animal models.
Badimon L
Thromb Haemost; 2001 Jul; 86(1):356-65. PubMed ID: 11487025
[TBL] [Abstract][Full Text] [Related]
4. [What are the criteria for choosing a model for evaluating arterial antithrombotic therapy?].
André P; Bal dit Sollier C; Bonneau M; Pignaud G; Hainaud P; Azzam K; Drouet L
Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1461-70. PubMed ID: 9092404
[TBL] [Abstract][Full Text] [Related]
5. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
6. In vivo thrombus formation in murine models.
Sachs UJ; Nieswandt B
Circ Res; 2007 Apr; 100(7):979-91. PubMed ID: 17431199
[TBL] [Abstract][Full Text] [Related]
7. [New insights into the etiopathogenesis of atherosclerosis and atherothrombosis].
Herman AG
Bull Mem Acad R Med Belg; 2006; 161(3-4):213-25; discussion 226-7. PubMed ID: 17172227
[TBL] [Abstract][Full Text] [Related]
8. The utility of animal models in the preclinical study of interventions to prevent human coronary artery restenosis: analysis and recommendations. On behalf of the Subcommittee on Animal, Cellular and Molecular Models of Thrombosis and Haemostasis of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.
Johnson GJ; Griggs TR; Badimon L
Thromb Haemost; 1999 May; 81(5):835-43. PubMed ID: 10365761
[TBL] [Abstract][Full Text] [Related]
9. Rupture of the atherosclerotic plaque: does a good animal model exist?
Cullen P; Baetta R; Bellosta S; Bernini F; Chinetti G; Cignarella A; von Eckardstein A; Exley A; Goddard M; Hofker M; Hurt-Camejo E; Kanters E; Kovanen P; Lorkowski S; McPheat W; Pentikäinen M; Rauterberg J; Ritchie A; Staels B; Weitkamp B; de Winther M;
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):535-42. PubMed ID: 12615660
[TBL] [Abstract][Full Text] [Related]
10. From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary prevention.
Chapman MJ
Pharmacol Ther; 2007 Jan; 113(1):184-96. PubMed ID: 17070923
[TBL] [Abstract][Full Text] [Related]
11. Platelet P2Y(12) receptor influences the vessel wall response to arterial injury and thrombosis.
Evans DJ; Jackman LE; Chamberlain J; Crosdale DJ; Judge HM; Jetha K; Norman KE; Francis SE; Storey RF
Circulation; 2009 Jan; 119(1):116-22. PubMed ID: 19103996
[TBL] [Abstract][Full Text] [Related]
12. Safety assessment of drug metabolites: implications of regulatory guidance and potential application of genetically engineered mouse models that express human P450s.
Powley MW; Frederick CB; Sistare FD; DeGeorge JJ
Chem Res Toxicol; 2009 Feb; 22(2):257-62. PubMed ID: 19170595
[TBL] [Abstract][Full Text] [Related]
13. A novel inhibitor of activated thrombin activatable fibrinolysis inhibitor (TAFIa) - part II: enhancement of both exogenous and endogenous fibrinolysis in animal models of thrombosis.
Wang YX; da Cunha V; Vincelette J; Zhao L; Nagashima M; Kawai K; Yuan S; Emayan K; Islam I; Hosoya J; Sullivan ME; Dole WP; Morser J; Buckman BO; Vergona R
Thromb Haemost; 2007 Jan; 97(1):54-61. PubMed ID: 17200771
[TBL] [Abstract][Full Text] [Related]
14. Vascular wall-produced prostaglandin E2 exacerbates arterial thrombosis and atherothrombosis through platelet EP3 receptors.
Gross S; Tilly P; Hentsch D; Vonesch JL; Fabre JE
J Exp Med; 2007 Feb; 204(2):311-20. PubMed ID: 17242161
[TBL] [Abstract][Full Text] [Related]
15. Vascular functions of the plasminogen activation system.
Fay WP; Garg N; Sunkar M
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1231-7. PubMed ID: 17379840
[TBL] [Abstract][Full Text] [Related]
16. Experimental models of thrombosis and atherosclerosis.
Verbeuren TJ
Therapie; 2006; 61(5):379-87. PubMed ID: 17243266
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of fenofibrate on plaque thrombogenicity and plaque stability in atherosclerotic rabbits.
Jeanpierre E; Le Tourneau T; Zawadzki C; Van Belle E; Mouquet F; Susen S; Ezekowitz MD; Staels B; Jude B; Corseaux D
Cardiovasc Pathol; 2009; 18(3):140-7. PubMed ID: 18436454
[TBL] [Abstract][Full Text] [Related]
18. Unstable coronary plaques and cardiac events in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits: questions and quandaries.
Shiomi M; Fan J
Curr Opin Lipidol; 2008 Dec; 19(6):631-6. PubMed ID: 18957890
[TBL] [Abstract][Full Text] [Related]
19. Effects of external electrical stimulation on laser-beam-induced experimental thrombosis.
Aguejouf O; Doutremepuich F; Doutremepuich C
Pathophysiol Haemost Thromb; 2006; 35(5):364-9. PubMed ID: 17230037
[TBL] [Abstract][Full Text] [Related]
20. Pro-thrombotic and pro-oxidant effects of diet-induced hyperhomocysteinemia.
Sauls DL; Arnold EK; Bell CW; Allen JC; Hoffman M
Thromb Res; 2007; 120(1):117-26. PubMed ID: 16979225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
